Profarma Direct Limited 08274127 false 2024-11-01 2025-10-31 2025-10-31 The principal activity of the company is that of packaging derma products. Digita Accounts Production Advanced 6.30.9574.0 true 08274127 2024-11-01 2025-10-31 08274127 2025-10-31 08274127 bus:Director1 1 2025-10-31 08274127 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 08274127 bus:Micro-entities 2024-11-01 2025-10-31 08274127 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 08274127 bus:FilletedAccounts 2024-11-01 2025-10-31 08274127 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 08274127 bus:RegisteredOffice 2024-11-01 2025-10-31 08274127 bus:Director1 2024-11-01 2025-10-31 08274127 bus:Director1 1 2024-11-01 2025-10-31 08274127 bus:Director3 2024-11-01 2025-10-31 08274127 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 08274127 countries:England 2024-11-01 2025-10-31 08274127 bus:Director1 1 2024-10-31 08274127 2023-11-01 2024-10-31 08274127 2024-10-31 08274127 bus:Director1 1 2024-10-31 08274127 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 08274127 bus:Director1 1 2023-11-01 2024-10-31 08274127 bus:Director1 1 2023-10-31 iso4217:GBP xbrli:pure

Registration number: 08274127

Profarma Direct Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 October 2025

Profarma Direct Limited

Contents

Company Information | 1
Statement of Financial Position | 2 to 3
Notes to the Unaudited Financial Statements | 2

Profarma Direct Limited

Company Information

Directors | Bill Stanford Benjamin Alexander Bidzinski

Registered office | Unit 8 Rinus Business Park Grimshaw Street Darwen Lancashire BB3 2QX

Accountants | S.B.P. (Southport) Limited T/A SB Patel & Co Chartered Certified Accountants Tolsey House 1 Marshside Road Churchtown Southport Merseyside PR9 9TL

Profarma Direct Limited

(Registration number: 08274127)
Statement of Financial Position as at 31 October 2025

| 2025 £ | 2024 £
Fixed assets | 6,579 | 2,995
Current assets | 109,341 | 41,425
Prepayments and accrued income | 79 | 491
Creditors: Amounts falling due within one year | (56,175) | (37,437)
Net current assets | 53,245 | 4,479
Total assets less current liabilities | 59,824 | 7,474
Accruals and deferred income | (2,780) | (2,660)
| 57,044 | 4,814
Capital and reserves | 57,044 | 4,814

1 | General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Unit 8
Rinus Business Park
Grimshaw Street
Darwen
Lancashire
BB3 2QX
England

These financial statements were authorised for issue by the Board on 10 June 2026.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 2).

Profarma Direct Limited

(Registration number: 08274127)
Statement of Financial Position as at 31 October 2025

3 | Related party transactions

Transactions with directors

2025 | At 1 November 2024 £ | At 31 October 2025 £
Bill Stanford
Directors Loan | 19,864 | 14,864

2024 | At 1 November 2023 £ | At 31 October 2024 £
Bill Stanford
Directors Loan | 18,762 | 19,864

For the financial year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Income Statement.

Approved and authorised by the Board on 10 June 2026 and signed on its behalf by:

......................................... Bill Stanford Director